Sign In
Buy JNJ
$244.88
+3.88 (+1.61%)
At Close: Jun 25, 2026
Johnson & Johnson expected to face dip in first-quarter earnings
01:35pm, Thursday, 11'th Apr 2024
Johnson & Johnson (NYSE:JNJ) will report first quarter results next Tuesday, 16 April, hot on the heels of its acquisition of Shockwave Medical. This US$13.1 billion deal saw J&J move further into th
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
01:10pm, Thursday, 11'th Apr 2024
Biotech stocks were among the worst performers in 2023. And so far in 2024, investors are still waiting on the recovery rally.
All-Time High Flyers: 7 Stocks to Buy as the Market Peaks
12:17pm, Thursday, 11'th Apr 2024
If you're wondering which stocks to buy in April, here's a good place to start. The stock market is off to a difficult start in the second quarter.
Rallybio partners with J&J to advance therapies targeting rare fetal disease
11:32am, Thursday, 11'th Apr 2024
Rallybio announced it is collaborating with Johnson & Johnson (NYSE:JNJ) on the development of therapies aimed at reducing the risk of a rare fetal disease called fetal and neonatal alloimmune thrombo
Unlocking Q1 Potential of Johnson & Johnson (JNJ): Exploring Wall Street Estimates for Key Metrics
10:20am, Thursday, 11'th Apr 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Johnson & Johnson (JNJ), delve into some of its key metrics to gain a deeper insight into the company's potential performance f
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
10:06am, Thursday, 11'th Apr 2024
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024
05:45pm, Wednesday, 10'th Apr 2024
The dividend kings are a select group of dividend stocks made up of companies that have increased their dividends for at least 50 consecutive years. That may be a throw-away statistic.
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
01:22pm, Wednesday, 10'th Apr 2024
With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access to health-related products and se
Nigeria recalls J&J children's cough syrup over toxic substance
11:50am, Wednesday, 10'th Apr 2024
Nigeria's health regulator is recalling a batch of Johnson & Johnson children's cough syrup after finding an unacceptably high level of a potentially fatal toxic substance, it said on Wednesday.
What's Next For Johnson & Johnson Stock After A 6% Decline In A Month?
08:30am, Wednesday, 10'th Apr 2024
Johnson & Johnson (NYSE: JNJ) recently announced its plans to acquire Shockwave Medical for $13 billion. Shockwave will help J&J extend its offerings in the cardiovascular intervention market.
If You Can Only Buy One Dividend Stock in April, It Better Be One of These 3 Names
06:25am, Wednesday, 10'th Apr 2024
Looking ahead, the future of the US economy is shaped by ongoing debates over interest rate policy and inflation. Recent robust economic data has led investors to anticipate fewer interest rate cuts b
Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?
04:57am, Wednesday, 10'th Apr 2024
Johnson & Johnson is buying Shockwave Medical for $13.1 billion. Shockwave is a profitable company that expects to generate more than $900 million in sales this year.
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
02:37pm, Tuesday, 09'th Apr 2024
J&J's cell therapy is now approved for an earlier line of treatment than a competing drug from Bristol Myers. Meanwhile, a look at Mount Sinai's approach to AI.
Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:06am, Tuesday, 09'th Apr 2024
Johnson & Johnson (JNJ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
04:21am, Tuesday, 09'th Apr 2024
AbbVie's dividend payout has more than tripled over the past decade, and it could soar much further in the decade ahead. Bristol Myers Squibb offers a juicy 4.7% dividend yield at recent prices.
